Transport by bus from Hotel Grand Joanne to site visits
Rigshospitalet, Rigshospitalets Innovation team and partners
The life expectancy is growing across the world resulting in a vast increase in the elderly population. At the same time, the number of people with chronic diseases is estimated to increase. This group of patients has a relatively high number of encounters with the healthcare system. At the same time, there is a current shortage of staff in the healthcare sector, which is expected to grow significantly in the future, making it difficult to meet the needs of the growing number of patients. However, innovative technology presents avenues for new prevention, treatment, and rehabilitation methods. During this site visit, the following question will be explored: How do we avoid lower quality in future treatments and ensure that innovation is incorporated and made possible as part of the solution?
Agenda:
09:00-09:30
Arrival and welcome with a brief introduction to Rigshospitalet incl. the Transformation Agenda – The Future Rigshospitalet
By Rasmus Møgelvang, MD PhD, CEO at Rigshospitalet
09:30-10:00
“Technical University Hospital of Greater Copenhagen (TUH) – a partnership which brings together experts from the Technical University of Denmark (DTU) and hospitals in the Capital Region of Denmark to create a collaborative environment where engineers and healthcare professionals can develop new solutions for patients.”
By Malene Fischer, Deputy Chief Executive, Research Director Rigshospitalet
10:00-10:30
“The Johnson & Johnson MedTech partnership – a one of a kind strategic partnership, which brings together the world-class clinicians of Rigshospitalet with the expertise, know-how, experience, size and reach of one of the world’s largest healthcare companies, and includes collaborations with both its pharmaceutical and MedTech businesses.”
By Martin Magelund, Member of the Executive Management Group and CEO of Centre of Head and Orthopedics, Rigshospitalet
and Julie Brooker, Country Director Denmark, Innovative Medicine, Johnson & Johnson
10:30-11:00
“BETA.HEALTH – Academy and Accelerator grant programme which supports innovation projects in Danish hospitals to spark the development of new or improved treatments and clinical solutions.”
By Rune Holdt, Director of Research and Innovation Rigshospitalet and BETA.HEALTH
11:00-11:15
Walk n’ network
11:15-12:00
“Introduction to and tour around Mary Elizabeth´s Hospital – a partnership between The Capital Region of Denmark, Rigshospitalet and Ole Kirk’s Fond to build a pioneering, first-rate hospital that sets new standards for the treatment of children, adolescents, pregnant women and their families.”
By Thomas Frandsen, Chief Medical Project Officer, Mary Elizabeths Hospital, Rigshospitalet
Venue: Rigshospitalet, Esther Møllers Vej 1, Copenhagen
Novo Nordisk Foundation and partners
What role do public-private partnerships play in advancing innovative health solutions in Denmark and what are we learning? This site-visit will present and discuss a variety of Danish public-private partnerships, which may include Danish Centre for AI Innovation, LightCOM focusing on healthy weight and NIVI (The Novo Nordisk Foundation Initiative for Vaccines and Immunity).
Agenda:
09:00-09:15
Arrival and welcome
By Steffen Pierini Lüders, SVP for Corporate Affairs, Novo Nordisk Foundation
09:15-09:35
“Introduction to Public-Private Partnerships from a Novo Nordisk Foundation-perspective and introduction to the Danish AMR Alliance incl. QA”
By Steffen Pierini Lüders, SVP for Corporate Affairs, Novo Nordisk Foundation
09:35-10:00
“AI innovation aiming to accelerate research and innovation in fields including healthcare and life sciences incl. QA”
By Lene Oddershede, SVP for Natural & Technical Sciences, Novo Nordisk Foundation
10:00-10:25
“NIVI – The Novo Nordisk Foundation Initiative for Vaccines and Immunity incl. QA”
By Hocine William Mankouri, Senior Scientific Lead, Infectious Diseases, Novo Nordisk Foundation
10:25-10:50
Break and networking
10:50-11:10
“Introduction to the Danish Lighthouse Life Science – Healthy Weight and the role of the private sector incl. QA”
By Anna Cichowska Myrup, MD FFPH, Associate Director, Global Obesity Policy, Novo Nordisk
11:10-11:30
“The Lighthouse Consortium on Obesity Management (LightCOM) incl. QA”
By Arne Astrup, SVP for Obesity & Nutritional Sciences, Novo Nordisk Foundation
11:30-11:55
Panel debate: “Global perspectives on multi-stakeholder and sector collaboration in healthcare”
Moderated by Diana Arsovic Nielsen, CEO of Danish Life Science Cluster
Panelists:
Prof. Bola Owolabi, Director, National Healthcare Inequalities Programme, NHS England
Dr., PhD. Megan Frisk, Director for International Affairs, Advanced Research Projects Agency for Health
Prof. Dr. Volker Amelung, Managing Partner, Institut für angewandte Versorgungsforschung
11:55-12:00
Closing remarks
By Peter Wiisbye, Senior Advisor at Healthcare Denmark
Venue: Novo Nordisk Foundation, Tuborg Havnevej 19, Hellerup
The Ministry of the Interior and Health of Denmark, Lundbeck, and Digital Psychiatry in the Region of Southern Denmark
Mental health and psychiatry are complex challenges, which are also acknowledged in Denmark’s 10-year plan for psychiatry and mental health. In recent years, it has become clear that the public system alone cannot solve these challenges. Through public-private partnerships, solutions that help people struggling with mental challenges are found, strengthening the overall approach to mental health in Denmark. The goal is to create a future where mental health is prioritised and accessible to all.
Agenda:
09:00-09:10
Arrival and welcome
By Karin Hamberg, CMO, Lundbeck
09:10-09:30
A patient’s story
09:30-09:50
“Introduction to Mental Health in Denmark and the Danish 10-year Psychiatry Plan.”
By Carlo V. Andersen, Head of Division, The Ministry of the Interior and Health
09:50-10:10
“Presentation of Danish Lighthouse Initiative’s focus on mental health incl. Introduction to some of the projects.”
By Karin Hamberg, CMO, Lundbeck
10:10-10:30
Break
10:30-10:50
“Digital psychiatry in Denmark and the need for innovative solutions.”
By Thomas L. Binzer, Team Leader, Center for Digital Psychiatry in the Region of Southern Denmark
10:50-11:10
Concrete example of a mental health solution
By Simon Lajboschitz, Co-Founder & CEO, Khora
11:10-11:55
Panel debate: “How public-private partnerships can assist in tackling the increase in psychiatric diseases incl. various perspectives.”
Moderated by Dr. Ruma Bhargava, Global Lead Mental Health, World Economic Forum
Panelists:
Carlo V. Andersen, The Ministry of the Interior and Health
Frank Bellivier, Ministry for Labour, Health and Solidarity, France
Karin Hamberg, Lundbeck
Thomas L. Binzer, Region of Southern Denmark
11:55-12:00
Closing remarks
By Karin Hamberg, CMO, Lundbeck
Venue: Lundbeck, Ottiliavej 9, Valby
Transport from site visits to joint site visit
Ferring Pharamacuticals, BII, ReproUnion and public instiution research partners
Declining birth rates is a matter of growing demographical concern in many countries and governments are increasingly developing strategies to assist aspiring parents and addressing barriers to building families. According to a 2023 WHO report, one in six couples struggle to have children. At every stage of the journey from conception to birth, millions of people around the world are unable to access the care, treatment and support they need to build a family. The declining fertility rate poses challenges for individuals and society alike.
This site-visit will provide insights into why declining fertility is a significant societal problem, not only in Denmark but worldwide and how cross-sector partnerships play an important role in tackling this and helping aspiring parents.
Agenda:
13:00-13:05
Arrival
13:05-13:15
Lunch and seating
13:15-13:20
Welcome and introduction to Ferring
By Jan Peutzfeldt, General Manager Ferring IPC
13:20-13:35
“Fertility policy in Denmark”
By Julie Kolding Olsen, Chief adviser, Healthcare Ethics, Ministry of The Interior and Health
13:35-13:40
“Introduction to the importance of addressing infertility with cross-sector collaboration in science and innovation”
By Casper Johansen, Head of External Innovation & Scientific Licensing, Ferring
13:40-13:55
“Cross-sector partnership example 1: ReproUnion”
By Prof. Henriette Svarre Nielsen, Clinical Professor, University of Copenhagen, Consultant, Depart. of Obstetrics & Gynaecology, Hvidovre Hospital
13:55-14:10
“Cross-sector partnership example 2: Bio Innovation Institute”
By Trine Bartholdy, Chief Business Officer, BII
14:10-14:15
Break
14:15-14:30
“Multi-stakeholder and multi-sector collaboration internationally”
By Lars Løkke Rasmussen, Minister for Foreign Affairs of Denmark
14:30-14:40
“Introduction to Project Family Safe Birth, and how Ferring collaborates with the WHO and WEF to provide women with access to quality care and treatment during pregnancy and childbirth.”
By Kelle Moley, VP, Reproductive Medicine and Maternal Health, Ferring
14:40-15:00
Q&A – thank you and departure
By Jan Peutzfeldt + All Speakers
Venue: Ferring Pharmaceuticals Pharmascience Center, Soundport, Amager Strandvej 405 , Kastrup
Transport by bus from joint site visit to Closing Reception
Reception venue: University of Copenhagen, Maersk Tower, Blegdamsvej 3B, Copenhagen
15:30-16:00
Arrival and registration
16:25-16:30
Welcome
By Henrik C. Wegener, Rector, University of Copenhagen
16:30-16:40
Closing remarks
By Morten Bødskov, Minister for Industry, Business and Financial Affairs of Denmark
16:40–18:00
Networking
Transport by bus from Closing Reception to Hotel Grand Joanne
